Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil in muscular dystrophy with neuronal NOS insufficiency
2010-024659-10Phase 3Completed
- Sponsor
- Rigshospitalet
- Start
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of sildenafil in muscular dystrophy (MD) and muscle diseases (NMD), sponsored by Rigshospitalet. Primary endpoint: Increase of blood flow and handgrip capacity. Started Jun 2011; status: completed.
02
Drugs
sildenafil
03
Conditions
muscular dystrophy (MD)muscle diseases (NMD)
Beyond the preview
Go deeper on 2010-024659-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-024659-10.